(Q46488895)

22 December 2017

title

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma (English)

1 reference

22 December 2017

0 references

Kemp JP

1

1 reference

22 December 2017

Dockhorn RJ

2

1 reference

22 December 2017

Shapiro GG

3

1 reference

22 December 2017

Nguyen HH

4

1 reference

22 December 2017

Reiss TF

5

1 reference

22 December 2017

Seidenberg BC

6

1 reference

22 December 2017

Knorr B

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

22 December 2017

The Journal of Pediatrics

published in

1 reference

22 December 2017

volume

133

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

424-428

1 reference

22 December 2017

cites work

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Leukotriene E4 and granulocytic infiltration into asthmatic airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Leukotrienes are potent constrictors of human bronchi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Standardization of Spirometry, 1994 Update. American Thoracic Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

The effect of regular inhaled albuterol on exercise-induced bronchoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Exercise-induced bronchospasm in children: effects and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Inhibition of exercise-induced asthma by theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

Demonstration by placebo response in asthma by means of exercise testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970281-1

10.1016/S0022-3476(98)70281-1

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

9738728

1 reference

22 December 2017